Third View Private Wealth LLC has acquired a new stake in Northrop Grumman Corporation, purchasing 5,063 shares valued at approximately $2.887 million during the fourth quarter. This move comes as institutional investors collectively own about 83.40% of the stock, despite recent insider selling amounting to $15.9 million. Analysts maintain a "Moderate Buy" rating for Northrop Grumman, with an average price target of $719.58, driven by positive operational momentum and strong Q1 earnings performance.

Third View Private Wealth LLC has acquired 5,379 shares of Deere & Company, marking a new position valued at approximately $2.504 million, bringing institutional ownership to 68.58%. Deere & Company recently surpassed its quarterly earnings expectations with $2.42 EPS on $9.61 billion revenue, and declared a quarterly dividend of $1.62 per share. Analyst consensus rates the stock as a "Moderate Buy" with a target price of $655.45.

Packaging Corp of America is a major player in the packaging industry, specializing in containerboard and corrugated products for sectors like food, beverages, and e-commerce. The company benefits from stable demand driven by e-commerce growth and a focus on sustainable, domestic manufacturing. Analysts generally view the stock positively, citing strong market position, dividend growth, and defensive qualities, while acknowledging risks from commodity price swings and competition.

Dow Inc. has announced that Karen S. Carter will become Chief Executive Officer effective July 1, 2026, while current Chair and CEO Jim Fitterling will transition to Executive Chair of the Board. Carter, with over 30 years at Dow, currently serves as Chief Operating Officer. The company's stock has performed strongly, rising 88% in the last six months, though InvestingPro analysis suggests it is overvalued relative to its Fair Value.

MassMutual Private Wealth & Trust, a subsidiary of the $584 billion insurance giant MassMutual, has expanded its cryptocurrency exposure by investing in the Bitwise XRP ETF, as revealed in a recent SEC filing. This move signals increasing institutional confidence in XRP, alongside their existing Bitcoin ETF holdings. The news coincides with a rise in XRP's price, fueled by growing whale accumulation, positive regulatory sentiment, and increased institutional interest, with spot XRP ETFs experiencing significant inflows.

Alkermes plc announced the publication of a 56-week post hoc analysis in The Journal of Clinical Psychiatry, revealing sustained reduction in negative symptoms of schizophrenia with LYBALVI. The study, derived from patients who completed ENLIGHTEN-1 and its 52-week extension, showed improvements in various subscale scores, further validating LYBALVI's utility for this challenging condition. This analysis highlights the drug's role in addressing hard-to-treat negative symptoms while also mitigating olanzapine-associated weight gain.

Labcorp has launched a new AI-powered real-world data platform, developed with Amazon Web Services (AWS) and Datavant, to accelerate Alzheimer's research and drug development. The platform utilizes de-identified healthcare data, including Labcorp's diagnostic and genomic datasets, combined with AI analytics to streamline data analysis, identify patient cohorts, and measure treatment effectiveness, ultimately aiming to shorten drug development timelines and improve patient outcomes. This innovation allows researchers to generate insights in minutes, significantly faster than traditional methods, and will expand to include other therapeutic areas in the future.

Otis (NYSE: OTIS) has launched its new Robust™ heavy-duty elevator range, specifically designed for multi-story data centers and other mission-critical infrastructure, supported by a global data center pipeline exceeding $2.5 trillion in anticipated investment. These elevators offer significantly increased weight capacity (up to 5x) and wider door openings (up to 2x) compared to standard passenger elevators, and are integrated with Otis ONE predictive maintenance. The move aims to address the rapid expansion of facilities fueled by cloud computing and AI, requiring faster deployment, continuous operation, and reliable high-capacity solutions.

Cardinal Health's 2026 Advanced Therapies Report indicates a strong trend towards delivering gene-, cell-, and tissue-based treatments in outpatient and community settings to enhance patient access and experience. The report, based on a survey of over 160 clinicians and administrators, highlights that while there are currently 61 approved advanced therapies in the U.S., projected to nearly triple by 2030, significant infrastructure, staffing, and partnership investments are crucial for safe community expansion. This shift is expected to increase health system capacity and improve patient outcomes for complex diseases.

CareCloud, Inc. announced securing a $50 million credit facility with Citizens Bank and Provident Bank, alongside the full redemption of its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock. This strategic move aims to simplify the company's capital structure, eliminate annual preferred dividend obligations of approximately $3.2 million, and enhance long-term financial flexibility and shareholder value. The redemption is expected to be completed on May 15, 2026, replacing higher-cost preferred equity with lower-cost institutional debt.